Diabetes Complications Across Organ Systems: Cardiovascular, Nervous, Eyes, Kidneys, Skin, Feet

Chronic hyperglycemia drives microvascular and macrovascular damage via advanced glycation end-products (AGEs), oxidative stress, PKC activation, and polyol pathway flux.

Cardiovascular (Macrovascular)

  • Accelerated atherosclerosis → coronary artery disease (MI, silent ischemia), cerebrovascular disease (stroke), peripheral artery disease (claudication, critical limb ischemia).
  • 2–4× higher CVD mortality.

Nervous System (Neuropathy)

  • Distal symmetric polyneuropathy: Stocking-glove numbness, pain, loss of proprioception → falls, ulcers.
  • Autonomic neuropathy: Gastroparesis, orthostatic hypotension, bladder atony, erectile dysfunction, anhidrosis.
  • Mononeuropathies: Cranial nerve palsies, median/ulnar/peroneal entrapment.

Eyes (Retinopathy)

  • Non-proliferative (microaneurysms, dot-blot hemorrhages, hard exudates) → proliferative (neovascularization, vitreous hemorrhage, traction retinal detachment).
  • Macular edema (central vision loss).
  • Leading cause of blindness in working-age adults.

Kidneys (Nephropathy)

  • Hyperfiltration → microalbuminuria (30–300 mg/g) → macroalbuminuria → declining eGFR → ESRD.
  • Diabetes = #1 cause of dialysis/transplant.

Skin

  • Diabetic dermopathy (shin spots), necrobiosis lipoidica, acanthosis nigricans, infections (fungal, bacterial), delayed wound healing.

Feet (Diabetic Foot Syndrome)

  • Neuropathy + PAD + trauma → ulceration → infection → osteomyelitis → amputation.
  • Prevention: daily inspection, offloading footwear, podiatry care, glucose control.

Unifying Management

Glycemic target (HbA1c <7% individualized), BP <130/80, statin, ACEi/ARB, SGLT2i/GLP-1 RA (cardio-renal benefit), annual screening (eye, foot, urine ACR, lipids).

Diabetes - Related Articles